Background: Intra-thoracic desmoid tumours with mediastinal invasion are very rare. Although rare they have to be taken into account in the differential diagnosis of a thoracic mass and therapeutic options have to be weighted since surgical treatment may require wide excision.
Background
Desmoid tumours are soft-tissue neoplasms arising from fascial or musculo-aponeurotic structures [1] . They are characterized by the proliferation of fibroblasts with no cytological evidence of malignancy and are organized in the form of fasciae. They are considered benign because of their cytological features and because they don't give rise to metastases [2] , but their biological behaviour is that of a locally aggressive tumour, relapse of which is not infrequent after surgical resection [3] .
Intra-thoracic desmoid tumours with invasion of the mediastinum are however rare. We report here a case of an intra-thoracic desmoid tumour in a patient previously operated on by sternotomy for a triple aorto-coronary bypass.
Case presentation
The patient was a 48-year-old male, diabetic, dyslipidaemic, former heavy smoker and suffering from paranoid schizophrenia, a triple aorto-coronary bypass was performed 4 years before by sternotomy. The patient was healthy till a few days before admission to the hospital, when he suffered constant oppressive chest pain.
Standard chest radiography followed by computed tomography (CT) scan and magnetic resonance imaging (MRI) showed a mass measuring 15 cm in diameter, located in the anterior mediastinum with extension to the right hemithorax (Figure 1, 2) . MRI showed a contiguity between the mass and the bypass grafts without signs of invasion (Figure 1, 2) . Electrocardiography (EKG) and exercise stress test were also negative for cardiac disorders a coronary angiography was however performed to confirm the patency and functioning of the bypass.
The patient, whose symptoms worsened, was submitted to surgery without further investigations since it was thought that a preoperative histological determination would not change the therapeutic approach.
The surgical approach was a re-sternotomy with opening of the right pleural cavity. Exploration revealed a mass abutting sternal periosteum from which it could be separated. The mass extended from the aortic arch into the anterior mediastinum and most of the right pleural cavity without invading the lung. The main surgical problem was to be able to preserve aorto-coronary bypass which consisted of three venous grafts from ascending aorta to the main coronary vessels. The mass was isolated starting from the aortic arch, a dissection plane was there found, making it possible to separate the venous grafts. Right pericardium was however infiltrated and was removed permitting radical excision of the mass. The postoperative course was uneventful and the patient was discharged on seventh postoperative day.
The histological examination of the mass revealed a mesenchymal tumour with fibromixoid features, the ultrastructure of which was that of an aggressive fibromatosis (Figure 3) . At a 3 years follow-up the patient is still recurrence free.
Discussion
Literature search revealed only one more case of an intrathoracic desmoid tumour in a patient with an aorto-coronary bypass, described by Kostonly et al., in 2001 [4] . Other cases of intra-thoracic tumours described in the literature are reported after a surgical trauma or after a thoracotomy [5, 6] , pulmonary lobectomy [7] and after silicone breast implants [8] with either involvement of the chest wall and an intra-thoracic growth.
The clinical picture of such tumours is not specific, meanly characterized by chest pain and/or dyspnoea due to compression of the airways or lung [5] . Radiological examination may be useful in indicating the presence of desmoid tumour, but diagnostic certainty and differential diagnosis with malignant tumours such as sarcoma can be achieved by histology. CT scans make it possible to define the location of the tumour, its behaviour with regard to contiguous organs as well as bone erosions [6] [7] [8] . At MRI, the behaviour of the tumour is heterogeneous related to fibrous tissue content, grade of cellularity and myxomatous degeneration which yields a signal of greater intensity in T2W1 when present to a greater extent [9, 10] , as in the case reported here. Different therapeutic approaches have been proposed for thoracic desmoid tumours. Surgical treatment is currently indicated. Resection must be as radical as possible since the quality of the excision appears to have an impact on recurrence rates. Partial resection of a desmoid tumour has been reported but the residual tumour was present at one year follow-up [2, 11] despite adjuvant chemotherapy [2] . Recurrences after radical surgery is anyway reported in up to 40% [12, 13] .
Cardoso et al., has reported radiotherapy combined with surgery in a patient where removal of the tumour required the sacrifice of the great vessels involved and their replacement with prostheses. In this case the patient was diseasefree at a 6-year followup [14] .
Surgical treatment of thoracic desmoid tumours have to take into account problems related to the resection of contiguous structures with their possible replacement either by autologus or prothesic graft with increased postoperative morbidity. In the case reported by Kostolny et al., the saphenous-vein coronary bypass, combined with anastomosis of the left internal mammary artery to the left anterior descending coronary artery, was infiltrated and the construction of a substitute saphenous-vein aortocoronary bypass proved therefore necessary [4] . In the case described here, the tumour could be separated from the bone and vascular structures of the mediastinum including the aorto-coronary bypass vessels, whereas the pericardium was resected, thus allowing a radical resection with no evidence of relapse at a three years follow up as a result.
Conclusion
Although surgical treatment of intra-thoracic desmoid tumours may require extensive resection with possible reconstruction, immediate relief of increasing symptoms and follow up results make it actually the best therapeutic option.
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